Privium Fund Management’s BioNTech BNTX Stock Holding History

Privium Fund Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.8M	Buy	30,100 +3,100	+11%	+$292K	0.51%	29
2026 Q1	$2.4M	Sell	27,000 -6,300	-19%	-$647K	0.5%	31
2025 Q4	$3.17M	Buy	33,300 +14,300	+75%	+$1.44M	0.58%	27
2025 Q3	$1.87M	Buy	19,000 +8,013	+73%	+$857K	0.34%	32
2025 Q2	$1.18M	Buy	+10,987	New	+$1.11M	0.25%	29

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Privium Fund Management's BNTX Position: Q2 2026 in Review

Privium Fund Management increased its BioNTech (BNTX) stake by 11% in Q2 2026, buying an estimated $292K and bringing the position to 30,100 shares worth $2.8M. The position accounts for 0.51% of the portfolio, ranked #29.

Privium Fund Management first reported a position in BNTX in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.17M in Q4 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Privium Fund Management held 30,100 shares of BioNTech worth $2.8M as of Q2 2026.
Privium Fund Management bought 3,100 BioNTech shares in Q2 2026, an estimated $292K.
BioNTech made up 0.51% of Privium Fund Management's portfolio in Q2 2026, its #29 holding.
Privium Fund Management first reported a position in BioNTech in Q2 2025 and has held it in 5 quarters since.
Privium Fund Management's BioNTech position peaked at $3.17M in Q4 2025.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Privium Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.